AASLD Notebook: Inventiva Eyes Second-To-Market Possibility In NASH

 
• By Joseph Haas
  
2023 AASLD
Inventiva, Viking and Terns updated their progress in NASH at AASLD 2023 • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business